CIP2A and hepatocellular carcinoma: Functional assays revealed that DUBR activated the Notch1 signaling pathway by upregulating cancerous inhibitor of protein phosphatase 2A (CIP2A) levels via sponging miR-520d-5p, leading to the enhancement of the stemness characteristics of the HCC cells and drug resistance (205).